<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="3.0" xml:lang="EN">
  <front>
    <journal-meta><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="publisher">pmed</journal-id><journal-id journal-id-type="nlm-ta">PLoS Med</journal-id><journal-id journal-id-type="pmc">plosmed</journal-id><!--===== Grouping journal title elements =====--><journal-title-group><journal-title>PLoS Medicine</journal-title></journal-title-group><issn pub-type="epub">1549-1676</issn><issn pub-type="ppub">1549-1277</issn><publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher></journal-meta>
    <article-meta><article-id pub-id-type="doi">10.1371/journal.pmed.0020085</article-id><article-categories>
        <subj-group subj-group-type="heading">
          <subject>Correspondence</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Neuroscience</subject>
          <subject>Biochemistry/Drug Discovery</subject>
          <subject>Geriatrics</subject>
          <subject>Neurological Disorders</subject>
        </subj-group>
        <subj-group subj-group-type="System Taxonomy">
          <subject>Neurology</subject>
          <subject>Dementia</subject>
          <subject>Pharmacology and toxicology</subject>
        </subj-group>
      </article-categories><title-group><article-title>Authors' Reply</article-title><alt-title alt-title-type="running-head">Correspondence</alt-title></title-group><contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Gandy</surname>
            <given-names>Sam</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup/>
          </xref>
          <xref ref-type="corresp" rid="n1">
            <sup>*</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Petanceska</surname>
            <given-names>Suzana</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup/>
          </xref>
        </contrib>
      </contrib-group><aff id="aff1">
<label>1</label>
				
				<addr-line>Farber Institute for Neurosciences, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America</addr-line>
				
			</aff><aff id="aff2">
<label>2</label>
				
				<addr-line>Nathan Kline Institute at New York University, Orangeburg, New York, United States of America</addr-line>
				
			</aff><author-notes>
        <corresp id="n1">E-mail: <email xlink:type="simple">samgandy@earthlink.net</email></corresp>
      <fn fn-type="conflict" id="n2">
        <p> The authors haves declared that no competing interests exist.</p>
      </fn></author-notes><pub-date pub-type="ppub">
        <month>3</month>
        <year>2005</year>
      </pub-date><pub-date pub-type="epub">
        <day>29</day>
        <month>3</month>
        <year>2005</year>
      </pub-date><volume>2</volume><issue>3</issue><elocation-id>e85</elocation-id><!--===== Grouping copyright info into permissions =====--><permissions><copyright-year>2005</copyright-year><copyright-holder>Gandy and Petanceska</copyright-holder><license><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><related-article page="e18" related-article-type="companion" vol="2" xlink:href="info:doi/10.1371/journal.pmed.0020018" xlink:title="research article" xlink:type="simple">
				<article-title>Modulation of Statin-Activated Shedding of Alzheimer APP Ectodomain by ROCK</article-title>
			</related-article><related-article page="e22" related-article-type="companion" vol="2" xlink:href="info:doi/10.1371/journal.pmed.0020022" xlink:title="synopsis" xlink:type="simple">
				<article-title>How Statins May Protect against Alzheimer Disease</article-title>
			</related-article><related-article page="e81" related-article-type="companion" vol="2" xlink:href="info:doi/10.1371/journal.pmed.0020081" xlink:title="correspondence" xlink:type="simple">
				<article-title>Cholesterol, Statins, and Alzheimer Disease</article-title>
			</related-article></article-meta>
  </front>
  <body>
    <sec id="s1">
      <title/>
      <p>We appreciate the note from Drs. Koudinov and Berezov [<xref ref-type="bibr" rid="pmed-0020085-b1">1</xref>]. In our opinion, no model has yet been presented that plausibly accounts for all the data on statins, cholesterol, amyloid-ß protein (Aß), and Alzheimer disease. In our paper [<xref ref-type="bibr" rid="pmed-0020085-b2">2</xref>], we present evidence that the isoprenoid pathway contributes to statin-activated shedding of the APP ectodomain in cultured cells. We do not yet know which (if any) other “cholesterol-related” Alzheimer phenomena are also attributable to modulation of isoprenoids, Rho, or ROCK.</p>
      <p>Previously, conventional wisdom held that Aß load and hypercholesterolemia were directly related, based on observations that high-fat diet aggravated amyloid pathology in plaque-forming mice [<xref ref-type="bibr" rid="pmed-0020085-b3">3</xref>,<xref ref-type="bibr" rid="pmed-0020085-b4">4</xref>,<xref ref-type="bibr" rid="pmed-0020085-b5">5</xref>]. More recently, however, the formulation that statins act simply via cholesterol-lowering fails to account for several observations that cannot immediately be reconciled, either with the original “dogma” or with each other.</p>
      <p>First, Fagan et al. [<xref ref-type="bibr" rid="pmed-0020085-b6">6</xref>] questioned the role of cholesterol as the final common pathway in Aß load specification, since, in their experiments, low cholesterol per se apparently had no impact on brain Aß load in plaque-forming transgenic mice. Then, equally puzzling pharmacological data emerged. Atorvastatin was shown to lower brain amyloid load and Aß levels, but brain cholesterol levels were unaffected by the drug [<xref ref-type="bibr" rid="pmed-0020085-b7">7</xref>]. In an apparent complete contradiction with the original observations, now, some investigators have been able to devise circumstances under which there is an inverse relationship between cholesterol and Aß, with low neuronal cholesterol increasing Aß generation [<xref ref-type="bibr" rid="pmed-0020085-b8">8</xref>], and vice versa [<xref ref-type="bibr" rid="pmed-0020085-b9">9</xref>]. These newer observations are unexpected and extremely puzzling, and no comprehensive explanation has yet emerged.</p>
      <p>For those readers seeking an update on this challenging area, we would direct your attention to the Alzheimer Research Forum Web page (<ext-link ext-link-type="uri" xlink:href="http://www.alzforum.org/new/detailprint.asp?id=1135" xlink:type="simple">http://www.alzforum.org/new/detailprint.asp?id=1135</ext-link>), where you will find an excellent review of the literature as well as a series of evaluations of how our data fit into existing scenarios and models regarding cholesterol, statins, cerebral amyloidosis, and the cognitive failure of Alzheimer disease.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pmed-0020085-b1">
        <label>1</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Koudinov</surname>
              <given-names>AR</given-names>
            </name>
            <name name-style="western">
              <surname>Berezov</surname>
              <given-names>TT</given-names>
            </name>
          </person-group>
          <article-title>Cholesterol, statins, and Alzheimer disease.</article-title>
          <source>PLoS Med</source>
          <year>2005</year>
          <volume>2</volume>
          <issue>3</issue>
          <fpage>e81</fpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b2">
        <label>2</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Pedrini</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Carter</surname>
              <given-names>TL</given-names>
            </name>
            <name name-style="western">
              <surname>Prendergast</surname>
              <given-names>G</given-names>
            </name>
            <name name-style="western">
              <surname>Petanceska</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Ehrlich</surname>
              <given-names>ME</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK.</article-title>
          <source>PLoS Med</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>e18</fpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b3">
        <label>3</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Refolo</surname>
              <given-names>LM</given-names>
            </name>
            <name name-style="western">
              <surname>Malester</surname>
              <given-names>B</given-names>
            </name>
            <name name-style="western">
              <surname>LaFrancois</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Bryant-Thomas</surname>
              <given-names>T</given-names>
            </name>
            <name name-style="western">
              <surname>Wang</surname>
              <given-names>R</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.</article-title>
          <source>Neurobiol Dis</source>
          <year>2000</year>
          <volume>7</volume>
          <fpage>321</fpage>
          <lpage>331</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b4">
        <label>4</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Levin-Allerhand</surname>
              <given-names>JA</given-names>
            </name>
            <name name-style="western">
              <surname>Lominska</surname>
              <given-names>CE</given-names>
            </name>
            <name name-style="western">
              <surname>Smith</surname>
              <given-names>JD</given-names>
            </name>
          </person-group>
          <article-title>Increased amyloid-levels in APPSWE transgenic mice treated chronically with a physiological high-fat high-cholesterol diet.</article-title>
          <source>J Nutr Health Aging</source>
          <year>2002</year>
          <volume>6</volume>
          <fpage>315</fpage>
          <lpage>319</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b5">
        <label>5</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Shie</surname>
              <given-names>FS</given-names>
            </name>
            <name name-style="western">
              <surname>Jin</surname>
              <given-names>LW</given-names>
            </name>
            <name name-style="western">
              <surname>Cook</surname>
              <given-names>DG</given-names>
            </name>
            <name name-style="western">
              <surname>Leverenz</surname>
              <given-names>JB</given-names>
            </name>
            <name name-style="western">
              <surname>LeBoeuf</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Diet-induced hypercholesterolemia enhances brain A beta accumulation in transgenic mice.</article-title>
          <source>Neuroreport</source>
          <year>2002</year>
          <volume>13</volume>
          <fpage>455</fpage>
          <lpage>459</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b6">
        <label>6</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Fagan</surname>
              <given-names>AM</given-names>
            </name>
            <name name-style="western">
              <surname>Christopher</surname>
              <given-names>E</given-names>
            </name>
            <name name-style="western">
              <surname>Taylor</surname>
              <given-names>JW</given-names>
            </name>
            <name name-style="western">
              <surname>Parsadanian</surname>
              <given-names>M</given-names>
            </name>
            <name name-style="western">
              <surname>Spinner</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis.</article-title>
          <source>Am J Pathol</source>
          <year>2004</year>
          <volume>165</volume>
          <fpage>1413</fpage>
          <lpage>1422</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b7">
        <label>7</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Petanceska</surname>
              <given-names>SS</given-names>
            </name>
            <name name-style="western">
              <surname>DeRosa</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Olm</surname>
              <given-names>V</given-names>
            </name>
            <name name-style="western">
              <surname>Diaz</surname>
              <given-names>N</given-names>
            </name>
            <name name-style="western">
              <surname>Sharma</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Statin therapy for Alzheimer's disease: Will it work?</article-title>
          <source>J Mol Neurosci</source>
          <year>2002</year>
          <volume>19</volume>
          <fpage>155</fpage>
          <lpage>161</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b8">
        <label>8</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Abad-Rodriguez</surname>
              <given-names>J</given-names>
            </name>
            <name name-style="western">
              <surname>Ledesma</surname>
              <given-names>MD</given-names>
            </name>
            <name name-style="western">
              <surname>Craessaerts</surname>
              <given-names>K</given-names>
            </name>
            <name name-style="western">
              <surname>Perga</surname>
              <given-names>S</given-names>
            </name>
            <name name-style="western">
              <surname>Medina</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Neuronal membrane cholesterol loss enhances amyloid peptide generation.</article-title>
          <source>J Cell Biol</source>
          <year>2004</year>
          <volume>167</volume>
          <fpage>953</fpage>
          <lpage>960</lpage>
        </nlm-citation>
      </ref>
      <ref id="pmed-0020085-b9">
        <label>9</label>
        <nlm-citation publication-type="journal" xlink:type="simple">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>George</surname>
              <given-names>AJ</given-names>
            </name>
            <name name-style="western">
              <surname>Holsinger</surname>
              <given-names>RM</given-names>
            </name>
            <name name-style="western">
              <surname>McLean</surname>
              <given-names>CA</given-names>
            </name>
            <name name-style="western">
              <surname>Laughton</surname>
              <given-names>KM</given-names>
            </name>
            <name name-style="western">
              <surname>Beyreuther</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease.</article-title>
          <source>Neurobiol Dis</source>
          <year>2004</year>
          <volume>16</volume>
          <fpage>124</fpage>
          <lpage>132</lpage>
        </nlm-citation>
      </ref>
    </ref-list>
    
  </back>
</article>